DOCSLIB.ORG

Prodynorphin Mrna Expression Is Increased in the Patch Vs Matrix

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Prodynorphin Mrna Expression Is Increased in the Patch Vs Matrix Molecular Psychiatry (1997) 2, 495–500 1997 Stockton Press All rights reserved 1359–4184/97 $12.00 ORIGINAL RESEARCH ARTICLE consistent with their specific distribution in the human striatum.11,12 Within the range studied, postmortem Prodynorphin mRNA interval (PMI) was not found to significantly influence the levels of prodynorphin, proenkephalin, or D1 and D2 receptor mRNAs expressed throughout the striatum expression is increased in (eg Spearman correlation values between PMI and pro- the patch vs matrix dynorphin mRNA levels measured in the caudate, putamen, and nucleus accumbens, were −0.0099, compartment of the −0.0474, and 0.0442, respectively). No significant cor- relations were found between proenkephalin, D1,orD2 caudate nucleus in suicide mRNA expression and age, sex, race, blood ethanol level, or freezer storage time of the brain tissue subjects samples. The same applied for the expression of levels of prodynorphin mRNA and these variables, except for YL Hurd1, MM Herman2, TM Hyde2,LB 2 2 2 age, where there was a positive correlation in the Bigelow , DR Weinberger and JE Kleinman nucleus accumbens (Spearman correlation: 0.7592; = 1Karolinska Institute, Dept of Clinical Neuroscience, P 0.0004; with Bonferroni inequality the significance Psychiatry Section, S-171 76 Stockholm, Sweden; 2Clinical level was 0.0017). To consider any possible contri- Brain Disorders Branch, NIMH, Neuroscience Center at St bution of age, ANOVA statistical evaluations were also carried out with covariance for age. Elizabeths Hospital, Washington DC 20032, USA As presented in Table 1, no significant group differ- ences were seen in the mRNA expression levels of pro- Keywords: opioid neuropeptides; limbic; striatum; enkephalin or D1 and D2 dopamine receptors measured depression; human; in situ hybridization; enkephalin; dopa- within the caudate, putamen, or nucleus accumbens. mine receptors Also, no significant group differences were apparent Experimental and clinical studies suggest an involve- for the prodynorphin hybridization signals measured ment of the opioid neuropeptide system in psychiatric within the total caudate, putamen, and nucleus accum- disorders. Notably, opioid peptide immunoreactivity is bens. Of the markers tested, however, the mRNA altered in the cerebrospinal fluid of chronic schizo- expression of prodynorphin in the human striatum phrenics and manic-depressive subjects.1–3 Despite showed a pronounced heterogeneous distribution pat- these clinical findings, few postmortem investigations4,5 tern, with cell clusters of high mRNA expression sur- have examined the association of endogenous opioid rounded by regions of low expression (Figure 1), con- neuropeptides with schizophrenia and suicide. Anatom- sistent with its patch/matrix striatal organization.9 ically, a tight interaction exists within the neostriatum ANOVA with age as a covariate revealed a significant between the opioid peptide (dynorphin and enkephalin) group difference (P = 0.027) of the prodynorphin system and classical neurotransmitters such as dopam- mRNA expression in the caudate nucleus patch com- ine6 which has been implicated in both the psychotic partment: suicide subjects expressed higher levels of symptoms and the cognitive deficits that characterize 7 prodynorphin mRNA than that measured in schizo- schizophrenia (see review). The neostriatum is differen- # tially organized into patch and matrix neurochemical phrenics (P 0.05; Tukey-Kramer), and a similar trend mosaic compartments anatomically connected to limb- (P # 0.1; Tukey-Kramer) when compared to normal ic- and sensorimotor-related brain regions, respect- controls (Table 1 and Figure 1). Prodynorphin mRNA ively.6,8 Moreover, the human neostriatum is charac- expression in the caudate nucleus patch compartment terized by a heterogenous expression of the of schizophrenic subjects was not significantly differ- prodynorphin opioid gene: high in the patch, but low in ent from normal controls. No significant group differ- the matrix compartment.9,10 The present results show ences were found for prodynorphin mRNA expression for the first time a differential alteration of prodynorphin levels measured in the matrix compartment of the cau- within distinct striatal compartments in postmortem date nucleus. Thus overall, the same group difference tissue from nonschizophrenic suicide subjects. The pro- (P = 0.018) was apparent for the prodynorphin dynorphin patch/matrix mRNA expression was elevated in the caudate nucleus of suicide subjects as compared patch/matrix ratio in the caudate nucleus: high to normal controls and schizophrenics in which no alter- patch/matrix prodynorphin mRNA expression in the suicide subjects vs the control (P # 0.05) and schizo- ations in opioid peptides or D1 and D2 mRNA expression were apparent. Altogether the findings suggest that dis- phrenic (P # 0.03) groups, and no change from control crete dysfunction of the endogenous opioid dynorphin for the schizophrenics. It was noted that although all system might contribute to depression and the risk of suicide victims showed elevated patch/matrix prody- suicide in nonschizophrenic subjects. norphin mRNA expression, one subject was found to The mRNA expression of prodynorphin, proenke- express very low prodynorphin mRNA throughout the phalin, and D1 and D2 receptors was assessed using in entire striatum, which could not be explained by any situ hybridization histochemistry. The hybridization documented clinical information. In the putamen, no signals obtained using selective oligonucleotides or statistically significant group difference was evident in riboprobes complementary to these mRNA transcripts either the patch or matrix compartment. showed unique hybridization patterns and intensities The failure to detect any significant differences in Prodynorphin mRNA expression in the striatum YL Hurd et al 496 Table 1 DPM mg−1 values (mean ± s.e.m.) in the striatum of schizophrenic, suicide, and normal control subjects Caudate Putamen Nucleus accumbens PDYN (total area) Normal 88.9 ± 3.0 84.6 ± 2.6 93.2 ± 6.0 Suicide 93.8 ± 2.8 90.9 ± 4.1 108.8 ± 10.7 Schizophrenic 84.6 ± 5.3 80.3 ± 5.5 101.3 ± 9.9 PDYN patch Normal 105.6 ± 2.7 97.2 ± 5.5 n.d. Suicide 120.5 ± 6.5b 103.9 ± 9.8 n.d. Schizophrenic 97.6 ± 6.1 80.9 ± 5.4 n.d. PDYN matrix Normal 54.1 ± 2.2 48.3 ± 7.2 n.d. Suicide 48.1 ± 5.4 43.9 ± 5.6 n.d. Schizophrenic 52.2 ± 4.9 39.8 ± 6.4 n.d. PDYN patch/matrix Normal 1.9 ± 0.10 2.2 ± 0.20 n.d. Suicide 2.6 ± 0.19a,b 2.4 ± 0.15 n.d. Schizophrenic 1.9 ± 0.17 2.2 ± 0.24 n.d. PENK Normal 125.8 ± 9.2 133.0 ± 8.8 129.1 ± 8.7 Suicide 133.3 ± 7.0 136.4 ± 6.0 139.7 ± 4.1 Schizophrenic 138.7 ± 6.4 141.9 ± 6.7 141.1 ± 6.5 D1 dopamine receptor Normal 65.3 ± 2.9 65.7 ± 3.1 65.2 ± 2.9 Suicide 66.7 ± 2.2 65.9 ± 2.3 67.2 ± 2.3 Schizophrenic 65.2 ± 0.7 65.2 ± 1.1 65.6 ± 0.8 D2 dopamine receptor Normal 85.4 ± 2.2 85.6 ± 1.6 80.5 ± 2.5 Suicide 83.9 ± 1.2 85.6 ± 1.6 84.5 ± 2.6 Schizophrenic 87.1 ± 3.3 86.8 ± 4.4 82.0 ± 2.5 PDYN, prodynorphin; PENK, proenkephalin; n.d., not determined. aP , 0.05, vs control; bP , 0.05 vs schizophrenic; Tukey-Kramer. 17 the mRNA levels of dopamine D1 and D2 receptors typically inducing dysphoric experiences in humans. expressed in the caudate, putamen, or nucleus accum- While the present study cannot directly address the bens of drug-free schizophrenics is also matched at the state of depression, if any, at the time of death, the fact protein level; negative results were also obtained for remains that depression is the single most important 18 D1 and D2 receptor sites using radioligand binding on risk factor for suicide. Moreover, the prodynorphin the same postmortem brain specimen currently exam- elevations were predominantly localized in the patch 13 ined. The lack of D2 receptor alterations found at compartment of the caudate nucleus which has sig- postmortem fits with in vivo imaging studies that have nificant implications for affect, since it is the patch stri- failed to detect any alterations of dopamine D2 receptor atal compartment that receives a greater input from density in drug-free schizophrenic patients.14 How- limbic brain regions such as the amygdala8 and allo- 6 ever, D1 and D2 receptor and proenkephalin mRNA cortices, in comparison to the matrix which is more expression were also found to be normal in schizo- closely linked to sensorimotor brain areas. phrenic subjects who had chronic neuroleptic treat- Although striatal prodynorphin neurons preferen- 15 19 ment prior to death. It is feasible that although the D1 tially express D1 dopamine receptors, no changes and D2 receptor sites are major targets of antipsychotic were detected in mRNA expression for this dopamine drugs, other dopamine receptor subtypes, eg D3 and D4, receptor subtype or for D2 mRNA expression in the that are more tightly linked to the limbic system, are suicide group. Again, the lack of any alteration of the 16 affected to a greater extent in schizophrenic subjects. mRNA expression of D1 and D2 receptors is consistent In contrast to the failure to detect any mRNA abnor- with the negative results observed for D1 and D2 recep- malities at the level of striatal organization currently tor-binding sites in these subjects13 and in other sui- studied in schizophrenics, the increased expression of cide victims free of antidepressants prior to death.20 prodynorphin mRNA in the patch compartment of the In addition to expressing high levels of prodynor- caudate nucleus provides the first postmortem evi- phin mRNA, the human patch compartment is charac- dence of mRNA abnormalities in the striatal opioid terized by high m receptor-binding sites.12 Recently, m peptide system in suicide victims.
Load more

Recommended publications
  • Analytical Performance of an Immunoassay to Measure Proenkephalin ⁎ Leslie J
    Clinical Biochemistry xxx (xxxx) xxx–xxx Contents lists available at ScienceDirect Clinical Biochemistry journal homepage: www.elsevier.com/locate/clinbiochem Analytical performance of an immunoassay to measure proenkephalin ⁎ Leslie J. Donatoa, ,Jeffrey W. Meeusena, John C. Lieskea, Deborah Bergmannc, Andrea Sparwaßerc, Allan S. Jaffea,b a Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, United States b Division of Cardiology, Mayo Clinic, Rochester, MN 55905, United States c Sphingotec GmbH, Hennigsdorf, Germany ARTICLE INFO ABSTRACT Keywords: Background: Endogenous opioids, enkephalins, are known to increase with acute kidney injury. Since the mature Biomarkers pentapeptides are unstable, we evaluated the performance of an assay that measures proenkephalin 119–159 Proenkephalin (PENK), a stable peptide formed concomitantly with mature enkephalins. Enkephalin Methods: PENK assay performance was evaluated on two microtiterplate/chemiluminescence sandwich im- Pro-enkephalin munoassay formats that required 18 or 1 h incubation times. PENK concentration was measured in plasma from penKid healthy individuals to establish a reference interval and in patients with varied levels of kidney function and Assay validation comorbidities to assess the association with measured glomerular filtration rate (mGFR) using iothalamate clearance. Results: Assay performance characteristics in plasma were similar between the assay formats. Limit of quanti- tation was 26.0 pmol/L (CV = 20%) for the 1 h assay and 17.3 pmol/L (CV = 3%) for the 18 h assay. Measurable ranges were 26–1540 pmol/L (1 h assay) and 18–2300 pmol/L (18 h assay). PENK concentrations are stable in plasma stored ambient to 10 days, refrigerated to at least 15 days, and frozen to at least 90 days.
    [Show full text]
  • From Opiate Pharmacology to Opioid Peptide Physiology
    Upsala J Med Sci 105: 1-16,2000 From Opiate Pharmacology to Opioid Peptide Physiology Lars Terenius Experimental Alcohol and Drug Addiction Section, Department of Clinical Neuroscience, Karolinsku Institutet, S-I71 76 Stockholm, Sweden ABSTRACT This is a personal account of how studies of the pharmacology of opiates led to the discovery of a family of endogenous opioid peptides, also called endorphins. The unique pharmacological activity profile of opiates has an endogenous counterpart in the enkephalins and j3-endorphin, peptides which also are powerful analgesics and euphorigenic agents. The enkephalins not only act on the classic morphine (p-) receptor but also on the 6-receptor, which often co-exists with preceptors and mediates pain relief. Other members of the opioid peptide family are the dynor- phins, acting on the K-receptor earlier defined as precipitating unpleasant central nervous system (CNS) side effects in screening for opiate activity, A related peptide, nociceptin is not an opioid and acts on the separate NOR-receptor. Both dynorphins and nociceptin have modulatory effects on several CNS functions, including memory acquisition, stress and movement. In conclusion, a natural product, morphine and a large number of synthetic organic molecules, useful as drugs, have been found to probe a previously unknown physiologic system. This is a unique develop- ment not only in the neuropeptide field, but in physiology in general. INTRODUCTION Historical background Opiates are indispensible drugs in the pharmacologic armamentarium. No other drug family can relieve intense, deep pain and reduce suffering. Morphine, the prototypic opiate is an alkaloid extracted from the capsules of opium poppy.
    [Show full text]
  • Identification of Β-Endorphins in the Pituitary Gland and Blood Plasma Of
    271 Identification of -endorphins in the pituitary gland and blood plasma of the common carp (Cyprinus carpio) E H van den Burg, J R Metz, R J Arends, B Devreese1, I Vandenberghe1, J Van Beeumen1, S E Wendelaar Bonga and G Flik Department of Animal Physiology, Faculty of Science, University of Nijmegen, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands 1Laboratory of Protein Biochemistry and Protein Engineering, University of Gent, KL Ledeganckstraat 35, B9000 Gent, Belgium (Requests for offprints should be addressed to G Flik; Email: gertfl[email protected]) Abstract Carp -endorphin is posttranslationally modified by N-acetyl -endorphin(1–29) and these forms together N-terminal acetylation and C-terminal cleavage. These amounted to over 50% of total immunoreactivity. These processes determine the biological activity of the products were partially processed to N-acetyl - -endorphins. Forms of -endorphin were identified in endorphin(1–15) (30·8% of total immunoreactivity) and the pars intermedia and the pars distalis of the pituitary N-acetyl -endorphin(1–10) (3·1%) via two different gland of the common carp (Cyprinus carpio), as well as the cleavage pathways. The acetylated carp homologues of forms released in vitro and into the blood. After separation mammalian - and -endorphin were also found. and quantitation by high performance liquid chroma- N-acetyl -endorphin(1–15) and (1–29) and/or (1–33) tography (HPLC) coupled with radioimmunoassay, the were the major products to be released in vitro, and were -endorphin immunoreactive products were identified by the only acetylated -endorphins found in blood plasma, electrospray ionisation mass spectrometry and peptide although never together.
    [Show full text]
  • Biased Signaling by Endogenous Opioid Peptides
    Biased signaling by endogenous opioid peptides Ivone Gomesa, Salvador Sierrab,1, Lindsay Lueptowc,1, Achla Guptaa,1, Shawn Goutyd, Elyssa B. Margolise, Brian M. Coxd, and Lakshmi A. Devia,2 aDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029; bDepartment of Physiology & Biophysics, Virginia Commonwealth University, Richmond, VA 23298; cSemel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095; dDepartment of Pharmacology & Molecular Therapeutics, Uniformed Services University, Bethesda MD 20814; and eDepartment of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA 94143 Edited by Susan G. Amara, National Institutes of Health, Bethesda, MD, and approved April 14, 2020 (received for review January 20, 2020) Opioids, such as morphine and fentanyl, are widely used for the possibility that endogenous opioid peptides could vary in this treatment of severe pain; however, prolonged treatment with manner as well (13). these drugs leads to the development of tolerance and can lead to For opioid receptors, studies showed that mice lacking opioid use disorder. The “Opioid Epidemic” has generated a drive β-arrestin2 exhibited enhanced and prolonged morphine-mediated for a deeper understanding of the fundamental signaling mecha- antinociception, and a reduction in side-effects, such as devel- nisms of opioid receptors. It is generally thought that the three opment of tolerance and acute constipation (15, 16). This led to types of opioid receptors (μ, δ, κ) are activated by endogenous studies examining whether μOR agonists exhibit biased signaling peptides derived from three different precursors: Proopiomelano- (17–20), and to the identification of agonists that preferentially cortin, proenkephalin, and prodynorphin.
    [Show full text]
  • Screening of 109 Neuropeptides on Asics Reveals No Direct Agonists
    www.nature.com/scientificreports OPEN Screening of 109 neuropeptides on ASICs reveals no direct agonists and dynorphin A, YFMRFamide and Received: 7 August 2018 Accepted: 14 November 2018 endomorphin-1 as modulators Published: xx xx xxxx Anna Vyvers, Axel Schmidt, Dominik Wiemuth & Stefan Gründer Acid-sensing ion channels (ASICs) belong to the DEG/ENaC gene family. While ASIC1a, ASIC1b and ASIC3 are activated by extracellular protons, ASIC4 and the closely related bile acid-sensitive ion channel (BASIC or ASIC5) are orphan receptors. Neuropeptides are important modulators of ASICs. Moreover, related DEG/ENaCs are directly activated by neuropeptides, rendering neuropeptides interesting ligands of ASICs. Here, we performed an unbiased screen of 109 short neuropeptides (<20 amino acids) on fve homomeric ASICs: ASIC1a, ASIC1b, ASIC3, ASIC4 and BASIC. This screen revealed no direct agonist of any ASIC but three modulators. First, dynorphin A as a modulator of ASIC1a, which increased currents of partially desensitized channels; second, YFMRFamide as a modulator of ASIC1b and ASIC3, which decreased currents of ASIC1b and slowed desensitization of ASIC1b and ASIC3; and, third, endomorphin-1 as a modulator of ASIC3, which also slowed desensitization. With the exception of YFMRFamide, which, however, is not a mammalian neuropeptide, we identifed no new modulator of ASICs. In summary, our screen confrmed some known peptide modulators of ASICs but identifed no new peptide ligands of ASICs, suggesting that most short peptides acting as ligands of ASICs are already known. Acid-sensing ion channels form a small family of proton-gated ion channels that belongs to the degenerin/epi- thelial Na+ channel (DEG/ENaC) gene family1.
    [Show full text]
  • 213393336.Pdf
    The Development of Analytical Methods for Investigations of Dynorphin A 1-17 Metabolism in the Central Nervous System and Peripheral Tissues and Transport at the Blood Brain Barrier By Courtney D. Kuhnline Sloan B.S., Investigative and Medical Sciences and Chemistry, Saint Louis University, 2005 M.S., Pharmaceutical Chemistry, The University of Kansas, 2008 Submitted to the Department of Pharmaceutical Chemistry and the faculty of the Graduate School of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. ________________________________ Chairperson- Dr. Susan M. Lunte ________________________________ Dr. Kenneth L. Audus ________________________________ Dr. John F. Stobaugh ________________________________ Dr. Teruna J. Siahaan ________________________________ Dr. Jane V. Aldrich Dissertation Defense: February 11, 2011 The Dissertation Committee for Courtney Kuhnline Sloan certifies that this is the approved version of the following dissertation: The Development of Analytical Methods for Investigations of Dynorphin A 1-17 Metabolism, in the Central Nervous System and Peripheral Tissues, and Transport at the Blood Brain Barrier ________________________________ Chairperson- Dr. Susan M. Lunte Date approved:_______________________ ii This dissertation is dedicated to my parents, Pam and Mike Kuhnline, for always pushing me to do my absolute best at everything I have ever attempted, and to my husband, Patrick, for his continual encouragement and willingness to spend our first months as a married couple with me buried under my thesis. This work was possible because of the unconditional love and support I have been so fortunate to have from each of you. iii Abstract Dynorphin A 1-17 (Dyn A 1-17) is an endogenous neuropeptide that acts preferentially at the kappa opioid receptor.
    [Show full text]
  • Opposing Roles of Cotransmission of Dynorphin and Hypocretin on Reward and Motivation Xuan Li1, Nathan J
    COMMENTARY COMMENTARY Opposing roles of cotransmission of dynorphin and hypocretin on reward and motivation Xuan Li1, Nathan J. Marchant, and Yavin Shaham1 Behavioral Neuroscience Research Branch, Intramural Research Program, Department of A Brain stimulation Cocaine self- reward administration Health and Human Services, National Institute on Drug Abuse, National Institutes of Health, Baseline Impulsive behavior Baltimore, MD 21224 Hypocretin Dynorphin In PNAS, Muschamp et al. (1) report that sleep homeostasis (12), and—most relevant HCRTR1 antagonist: KOR signal dominates hypocretin and dynorphin are coexpressed in to the present study—the rewarding effects the same synaptic vesicles of hypothalamic of cocaine and other rewards via its action neurons. Their data from behavioral, phar- on VTA dopamine neurons (13, 14). macological, and electrophysiological studies In 2001, Chou et al. (15) reported that HCRTR1 antagonist + KOR antagonist: Balance restored suggest that hypocretin and dynorphin are hypocretin and dynorphin colocalize in the coreleased, and that they play opposing roles same hypothalamic neurons (15). In 2006, Li in cocaine self-administration, brain stimula- and van den Pol (16) extended these findings ’ tion reward, and impulsivity. The authors and provided electrophysiological data in- B Ventral tegmental area: data also suggest that the critical brain site for dicating that inhibitory dynorphin and ex- these opposing effects of coreleased hypocre- citatory hypocretin are simultaneously tin and dynorphin is the ventral tegmental coreleased after stimulation of hypothalamic area (VTA), the cell body region of the hypocretin neurons. The functional signifi- mesolimbic dopamine reward system (2). cance of hypocretin/dynorphin corelease is un- Fig. 1 provides a summary of the main find- known, because despite the above-mentioned ings from the study.
    [Show full text]
  • Regulatory Strategies for Promoting the Safe Use of Prescription Opioids and the Potential Impact of Overregulation
    REGULATORY STRATEGIES FOR PROMOTING THE SAFE USE OF PRESCRIPTION OPIOIDS AND THE POTENTIAL IMPACT OF OVERREGULATION Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels „Master of Drug Regulatory Affairs“ der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn vorgelegt von Dr. Katja Bendrin aus Torgau Bonn 2020 Betreuer und Erster Referent: Dr. Birka Lehmann Zweiter Referent: Dr. Jan Heun REGULATORY STRATEGIES FOR PROMOTING THE SAFE USE OF PRESCRIPTION OPIOIDS AND THE POTENTIAL IMPACT OF OVERREGULATION Acknowledgment │ page II of VII Acknowledgment I want to thank Dr. Birka Lehmann for her willingness to supervise this work and for her support. I further thank Dr. Jan Heun for assuming the role of the second reviewer. A big thank you to the DGRA Team for the organization of the master's course and especially to Dr. Jasmin Fahnenstich for her support to find the thesis topic and supervisors. Furthermore, thank you Harald for your patient support. REGULATORY STRATEGIES FOR PROMOTING THE SAFE USE OF PRESCRIPTION OPIOIDS AND THE POTENTIAL IMPACT OF OVERREGULATION Table of Contents │ page III of VII Table of Contents 1. Scope.................................................................................................................................... 1 2. Introduction ......................................................................................................................... 2 2.1 Classification of Opioid Medicines .................................................................................................
    [Show full text]
  • Narcotic Analgesics I Blanton SLIDE 1: We Will Be Spending the Next 90 Minutes Discussing Narcotic Analgesics- That Is Morphine, Oxycodone, Heroin, Etc
    Narcotic Analgesics I Blanton SLIDE 1: We will be spending the next 90 minutes discussing narcotic analgesics- that is morphine, oxycodone, heroin, etc. These drugs act primarily thru the opiate receptor system. I always like to begin by presenting two factoids that I believe illustrate the power of this system: (1) Ok imagine you are in pain! Now I tell you that I am going to give you an injection of morphine or heroin. Even if I instead give you an injection of just saline- 50% of you will report that your pain is significantly reduced- that is quite a placebo effect. However, if instead of saline I give you an injection of Naloxone, an opiate receptor antagonist- the placebo effect is eliminated. In other words you are activating your opiate receptor system to induce analgesia. (2) acupuncture can be used to reduce pain. However, Naloxone will block this effect- in otherwords the acupuncture is activating your opiate receptor system. SLIDE 1A: The use of narcotic analgesics for effective pain management has certainly had its flip side……. With prescription narcotic analgesics helping to fuel the current heroin epidemic…. Back to SLIDE 1: So narcotic analgesics. The name narcotic is somewhat misleading, because it implies narcosis or somnolence. The name opiate or opioid is more precise because it connotes analgesia, without causing sleep or loss of consciousness. SLIDE 2: The terms opiate or opioid, as you are probably aware, refers to opium, the crude extract of the Poppy plant, Papaver somniferum. Opium comes from the seed pod of the plant after the petals have dropped.
    [Show full text]
  • The Role of Protein Convertases in Bigdynorphin and Dynorphin a Metabolic Pathway
    Université de Montréal The Role of Protein Convertases in Bigdynorphin and Dynorphin A Metabolic Pathway par ALBERTO RUIZ ORDUNA Département de biomédecine vétérinaire Faculté de médecine vétérinaire Mémoire présenté à la Faculté de médecine vétérinaire en vue de l’obtention du grade de maître ès sciences (M.Sc.) en sciences vétérinaires option pharmacologie Décembre, 2015 © Alberto Ruiz Orduna, 2015 Résumé Les dynorphines sont des neuropeptides importants avec un rôle central dans la nociception et l’atténuation de la douleur. De nombreux mécanismes régulent les concentrations de dynorphine endogènes, y compris la protéolyse. Les Proprotéines convertases (PC) sont largement exprimées dans le système nerveux central et clivent spécifiquement le C-terminale de couple acides aminés basiques, ou un résidu basique unique. Le contrôle protéolytique des concentrations endogènes de Big Dynorphine (BDyn) et dynorphine A (Dyn A) a un effet important sur la perception de la douleur et le rôle de PC reste à être déterminée. L'objectif de cette étude était de décrypter le rôle de PC1 et PC2 dans le contrôle protéolytique de BDyn et Dyn A avec l'aide de fractions cellulaires de la moelle épinière de type sauvage (WT), PC1 -/+ et PC2 -/+ de souris et par la spectrométrie de masse. Nos résultats démontrent clairement que PC1 et PC2 sont impliquées dans la protéolyse de BDyn et Dyn A avec un rôle plus significatif pour PC1. Le traitement en C-terminal de BDyn génère des fragments peptidiques spécifiques incluant dynorphine 1-19, dynorphine 1-13, dynorphine 1-11 et dynorphine 1-7 et Dyn A génère les fragments dynorphine 1-13, dynorphine 1-11 et dynorphine 1-7.
    [Show full text]
  • The Role of Dynorphin in the Onset of Puberty in Female Lambs
    Graduate Theses, Dissertations, and Problem Reports 2015 The Role of Dynorphin in the Onset of Puberty in Female Lambs Justin Angelo Lopez Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Lopez, Justin Angelo, "The Role of Dynorphin in the Onset of Puberty in Female Lambs" (2015). Graduate Theses, Dissertations, and Problem Reports. 6110. https://researchrepository.wvu.edu/etd/6110 This Thesis is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Thesis in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Thesis has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. The Role of Dynorphin in the Onset of Puberty in Female Lambs by Justin Angelo Lopez Thesis submitted to the Davis College of Agriculture, Natural Resources and Design at West Virginia University in partial fulfillment of the requirements for the degree of Master of Science in Reproductive Physiology Robert L. Goodman, Ph.D., Chair Stanley M. Hileman, Ph.D. Robert A. Dailey, Ph.D. Reproductive Physiology Morgantown, West Virginia 2015 Keywords: sheep, puberty, dynoprhin, kisspeptin, KNDy Copyright 2015 Justin Angelo Lopez ABSTRACT The Role of Dynorphin in the Onset of Puberty in Female Lambs Justin Angelo Lopez The neural mechanisms underlying the onset of puberty are not well understood.
    [Show full text]
  • Calcitonin Gene-Related Peptide and Other Peptides
    P1: KWW/KKL P2: KWW/HCN QC: KWW/FLX T1: KWW GRBT050-16 Olesen- 2057G GRBT050-Olesen-v6.cls July 9, 2005 4:30 ••Chapter 16 ◗ Calcitonin Gene-Related Peptide and Other Peptides Susan Brain and Lars Edvinsson Vasoactive peptides can be either stored or synthesized de THE CGRP FAMILY OF PEPTIDES novo before release from a range of tissues in the brain or from the walls of intracranial vasculature. In this chapter, The expression of mRNA from the calcitonin gene is tissue we concentrate on neuropeptides that are released from specific in that CGRP mRNA is predominantly expressed perivascular nerves. These include calcitonin gene-related in nerves and calcitonin mRNA in the thyroid (5). The 37 peptide (CGRP), substance P, neurokinin A, nociceptin, amino acid peptide CGRP belongs to a family that include somatostatin, and opioids (Table 16-1). The endothelium the more recently discovered peptides adrenomedullin produces the potent vasoconstrictors endothelin and an- that is primarily produced by non-neuronal tissues, espe- giotensin, and dilators such as nitric oxide, prostacyclin, cially vascular tissues and amylin that is mainly produced and endothelium-derived hyperpolarizing factors. In ad- in the pancreas. They share some structural homology (ap- dition there are circulating agents; among these the most proximately 25–40%) and also some, but not total, similar- potent is 5-hydroxytryptamine. The neuronal messengers ities in biological activities (see Brain and Grant [11] for stored in the intracranial vessels have been reviewed recent review). CGRP is abundant in the body and has a (32) and it was revealed that sympathetic nerves store wide distribution throughout the central and peripheral noradrenaline, neuropeptide Y, and ATP, the parasympa- nervous systems.
    [Show full text]